Selectins interact with giycoconjugate ligands in important normal and pathological situations. While high affinity recognition of natural ligands is associated with otl-3(4)fucosylated, o2-3sialylated (and/or sulfated) lactosamine sequences, small oligosaccharides that potently inhibit the selectins have not been found. One possibility suggested by other investigators is that high affinity may require unusual sequences not yet tested, for example, the "major capping group" (6'-sulfo-sialyl Le x ) of the Lselectin ligand GlyCAM-1. To explore this possibility, we synthesized a spectrum of novel synthetic and semisynthetic oligosaccharides related to those on natural ligands. In studying these molecules, we noted that binding of recombinant soluble selectins to immobilized sialyl Le x or 3'-sulfo-Le x is markedly inhibited by concentrations of chloride above the physiological range. This indicates the ionic nature of the interactions, and shows that buffers typically used in screening assays for inhibitors are not optimal. Using parameters that more closely approximate physiological conditions, we confirmed that a2-3-linked sialic acids, and al-3(4)fucosylation are important for recognition. Similar results obtained with both types of immobilized targets for the three selectins indicated that the binding sites for sialic acid and sulfate are very close, or identical. While O-suIfate esters mostly improved L-and P-selectin recognition, effects depended upon their position and number. Furthermore, sulfation can also impart some "negative" specificity: the major capping group does not interact with E-selectin. The branched Core 2 sequence seemed to enhance L-and P-selectin binding, however, the best inhibitors still appeared to be sialyl Le" and 3'-sulfoLe x , with the aglycone group of the latter affecting binding. Of particular note, the "major capping group" of Gly-CAM-1 was not an unusually potent nor highly selective inhibitor of L-selectin, even when studying the interaction of L-selectin with native GlyCAM-1 itself.
Introduction
The selectins are mammalian lectins that mediate the early steps of the recruitment of leukocytes from the blood stream in a variety of normal and pathologic situations (see Varki, 1992 Varki, , 1994 Bevilacqua and Nelson, 1993; Rosen and Bertozzi, 1994; Lasky, 1995; McEverera/., 1995 ; for reviews). Several natural giycoconjugate ligands of the selectins have been described, many of which share the biochemical properties of sialomucins (reviewed in Rosen and Bertozzi, 1994; Varki, 1994; Lasky, 1995; McEver et al, 1995) . GlyCAM-1 is the prototypic member of the "peripheral addressins," a group of sialylated sulfated mucin-like ligands for L-selectin synthesized by the specialized high endothelial venules (HEV) of lymphatic tissues (Imai et al, 1991; Lasky et al., 1992) , which includes CD-34 (Imai et al., 1991; Baumhueter et al., 1993) , the mucosal addressin-cell adhesion molecule-1 (MAdCAM-1) (Berg et al., 1993) , and an as yet unidentified 200 kDa ligand (Rosen and Bertozzi, 1994) . The O-linked glycans on GlyCAM-1 are sialylated, fucosylated, and sulfated (Imai and Rosen, 1993; Hemmerich and Rosen, 1994; Hemmerich et al., 1994) , and the sialic acids and sulfate esters are required for binding by Lselectin. With all three ligands, only glycoforms expressed by HEV cells are able to bind L-selectin, indicating the importance of tissue-specific glycosylation in recognition. Likewise, the polypeptides PSGL-1 (P-selectin glycoprotein ligand-1) and ESL-1 (E-selectin ligand-1) can generate high affinity ligands for P-and E-selectin only when expressed in the correct cell types (Moore et al, 1992; Norgard et al., 1993b; Sako et al., 1993) . In the case of PSGL-1, recent data indicates that high affinity recognition is mediated at least in part by the combined recognition of sialylated oligosaccharides and tyrosine sulfate residues (Pouyani and Seed, 1995; Sako et al., 1995; Wilkins et al., 1995) .
All three selectins are known to selectively recognize the tetrasaccharide sialyl-Le x (sLe x ; Siaa2-3Gal(31^4(Fucal-3)GlcNAcpi-R) and its isomer sialyl-Le" (sLe a ; Siaa2-3Gaipi-3(Fucal-4)GlcNAcpi-R). Many studies indicate that the sialic acid and the fucose residues are essential for recognition, and mat a sulfate ester can replace sialic acid in some instances (Yuen et al., 1994) . However, the affinity of the selectins for these oligosaccharides and for some of their derivatives appears to be poor (most studies report values in the high micromolar to low mM range, based upon IC^s and binding-inhibition assays, see Brandley et al., 1993; Nelson et al., 1993a,b; Narasinga Rao et al., 1994; Yoshida et al, 1994) . Recently, the directly measured K d for the interaction of soluble, monomeric E-selectin with the tetrasaccharide Siaa2-3Gaipi-4(Fucal-3)Glc was reported to be 120 JJLM (Jacob et al., 1995) . In contrast, the physiological ligands seem to have much better affinities, showing binding interactions that can survive stringent washing under a variety of conditions. Direct measurements have confirmed the better affinities, for ex- sylated oligosaccharides, which are responsible for the high affinity interaction. The best candidate to date is unusual oligosaccharide 6'-sulfo-SLe\ which was found on GlyCAM-1 (Hemmerich et al., 1994; Hemmerich and Rosen, 1994) , carrying an O-sulfate ester at the 6'-position of the galactose residue in SLe x . In a recent study, it was concluded that "this structure can account for all of the known carbohydrate requirements in the binding of L-selectin to its cognate HEV ligands" (Hemmerich et al., 1995) . Our recent successful synthesis of this compound prompted us to examine if this molecule is indeed a superior ligand for Lselectin. In pursuing this matter, we have demonstrated the ionic nature of selectin binding, optimized the conditions for in vitro inhibitor screening assays, and synthesized for comparison several other related sulfated sialylated fucosylated oligosaccharides.
Results and discussion

Rationale for selection of synthetic oligosaccharide targets as potential inhibitors of the selectins
Most prior studies of the inhibitory properties of sialyloligosaccharides have focused upon a single selectin or upon a limited range of inhibitors. We decided to directly compare all three selectins against a wide range of potential inhibitors in ample, a Kj of 70 nM for monomeric, soluble P-selectin interacting with its native ligand on HL-60 cells (Ushiyama et al., 1993) , and a similar affinity predicted for monovalent Eselectin (Hensley et al., 1994) .
There are currently several theories to explain the disparity between the high affinities of the selectins for their natural ligands and the relatively poor affinities of the common sialylated/sulfated fucosylated lactosamines. Simple multivalency of both oligosaccharide and selectin on intact cell surfaces or by presentation on a polypeptide backbone could enhance avidity. Indeed, while the IC^ of dimeric SLe* for E-selectin showed only a fivefold improvement over the monomeric form (DeFrees ef al., 1995) , a tetravalent form showed considerable improvement in inhibiting L-selectin (Turunen et al., 1995) . However, P-and L-selectin do not bind to some cell types that express considerable amounts of SLe*, and cell recognition is usually destroyed by the mucin-degrading enzyme O-sialoglycoprotease (Steininger et al., 1992; Norgard et al., 1993b; Ushiyama et al., 1993; Mannori et al, 1995) , even when the vast majority of cell surface SLe x remains intact after this treatment (Norgard et al., 1993b) . Thus, simple ligand multivalency seems insufficient to explain biologically relevant selectin binding. Another possibility is the multivalent aggregation of selectins. However, the high affinity binding of soluble monomeric E-and P-selectin to cell surfaces (Ushiyama et al., 1993) indicates that this is not essential, and there is no published evidence to date for naturally occurring multimerization of selectins. The possibility of multiple binding sites within a single selectin lectin domain is unlikely based on epitope mapping, mutagenesis, and crystallographic data, which indicate that the binding sites for carbohydrates is quite small (Erbe et al., 1992 (Erbe et al., , 1993 Hollenbaugh et al., 1993; Graves et al., 1994 ).
An alternate hypothesis is that the natural selectin ligands carry rare structural variants of the common sialylated fuco- ; (e) MeOH-hydrazine hydrate, 5:1 (v/v), 80°C, 7 h, (0 ACjO (excess), MeOH-CH 2 Cl 2 (1:1), 0°C, 1 h; MeOH-MeONa, 48 h, 53% from 19. Scheme 2. Reagents and conditions: (a) 2 equiv. of 14A, 1 equiv. of 18, 2 equiv. of AgOTf, 1.8 equiv. of 2,6-di-tertbutyl-4-methyl-pyridine, 4A molecular sieves, CH 2 Cl 2 -toluene, 2:3 (v/v), -35°C, 3 h, 79%; (b) EtOH-hydrazine hydrate, 9:1 (v/v), 100°C, 6 h, MeOH-EtjN-AcjO, 4:2:1 (v/v) 0 to 20°C, 2 h, 62%; (c) 2.5 equiv. of 13, 3 equiv. of NIS-triflic acid in propionitrile, -75°C, 2 h, 66%; (d) 6 equiv. of SO 3 -pyridine complex in pyridine, 5°C, 16 h; (e) MeOH, 10% Pd-C, MeOH-MeONa, 72 h, H 2 O, 5 h, 2 (96%), 3 (37% from 21). Scheme 3. Reagents and conditions: (a) 1.5 equiv. of 8, 1.0 equiv. of 12, 1.5 equiv. of Hg(CN>2 in benzene-nitromethane, 1:1 (v/v), 55°C, 16 h, 65%; (b) 1.0 equiv. of 23, 2.0 equiv. of 14, 3.0 equiv. of CuBr 2 , 3.0 equiv. of Bu 4 NBr, C1CH 2 CH 2 C1-DMF, 5:1 (v/v), 4A molecular sieves, 16 h, 56%; (c) 2.5 equiv. of 13, 3.0 equiv. of NIS-triflic acid in propionilrik, -70°C, 2 h, 54%; (d) 6 equiv. of SO 3 -pyridine complex in pyridine, 5°C, 16 h; (e) MeOH-10% Pd-C, MeOH-MeONa, 72 h, H 2 O, 5 h, 4 (66%), 5 (50% from 25). ELISA assays that used two different immobilized ligands. The selection of oligosaccharide targets for synthesis was based mainly on three considerations: (1) existing knowledge of natural oligosaccharide structures containing fucose, sulfate and sialic acid; and (2) knowledge of the specificity characteristics of fucosyl, sialyl, and sulfotransferases involved in their synthesis; and (3) some limitations on the ability to chemically synthesize all possible structures. Biosynthetic pathways indicate that sialylation occurs before fucosylation. Thus, Neu5Aca2-3Gal|31-(3)4GlcNAc(3-sequences are acceptors for ot-fucosyltransferases (Howard et al., 1987; Foster et al., 1991) to give sialyl-Le* and sialyl-Le* (see Figure 1 ). In contrast, Neu5Acat2-6Gal(31-4GlcNAc[3-is not an acceptor for al-3-fucosyltransferase (Paulson et al., 1978) and synthetically prepared Neu5Aca2-6Gaipi^t(Fuca(l-3)GlcNAcpidoes not bind to selectins. One of us (Chandrasekaran et al., 1995) first employed synthetic sulfated oligosaccharides to examine the specificity of ot-fucosyltransferases. For example, we found that SE-3Gal(31-4GlcNAc is an acceptor for a 1-3-fucosyltransferase to give SE-3Gal(31-4(Fucal-3)GlcNAc (Chandrasekaran et al., 1995) . We and others (Nicolaou et al., 1992; Lubineau et al., 1993; Chandrasekaran et al., 1995) also developed the chemical synthesis of this molecule, and showed that it can act as a ligand for selectins. Also, in examining the specificity of a2-3-sialyltransferase with a series of sulfated saccharides, we found that Gal|31^4(SE-6GlcNAc) is an effective acceptor for 2-3-sialyltransferase to give Neu5Acot2-3Gaipi^(SE-6)GlcNAc (Chandrasekaran etal., 1995; unpublished observations) . The resulting 2,3-sialylated compounds can be fucosylated by al-3-fucosyltransferase to give 6-sulfosialyl-Le x ,which others have recently shown to have a moderate affinity for L-selectin (Scudder et al., 1994) . This compound is an isomer of the "major capping group" on Gly-CAM-1 (6'-sulfated sialyl Le x ) (Hemmerich and Rosen, 1994) . Thus, certain sialylated and/or sulfated saccharides are capable of acting as acceptors for the al-3(4)-fucosyltransferases to yield products which can act as a ligand for selectins. More recently, others reported some bisulfated molecules to be mod- erately good L-selectin inhibitors (Bertozzi et al., 1995; Manning et al., 1995) Synthesis of compound 42 was based upon our recent findings on the specificity of 3-O-sulfotransferase from ovarian, colon, and breast tissues (Kuhns et al., 1995; Chandrahekaran et al., unpublished observations) . This enzyme, particularly from ovarian and breast tissue, is highly specific for C-3 position of galactose in the Gaipi-3GalNAc sequence. Corresponding to this finding, the synthetic analog of 42 without the sulfate functional group is a very good acceptor for the transfer of sulfate onto 42 via 3-O-sulfotransferase. In addition to these linear structures, many selectin ligands are characterized by O-linked mucin core structures, which can be branched. In the case of GlyCAM-l,the inner core structure Galpl4GlcNAcpi^6(Gaipi-3)GalNAcal-is further modified by sialic acid, sulfate, and fucose to give one of the larger oligosaccharide moieties on this protein (Hemmerich et al., 1995) . Thus, we also focused our attention on trying to synthesize some of these branched molecules. Synthetic methods used included the use of 2,3,4-tri-Oacetyl-6-O-pivaloyl-a/b-galactopyranosyl halide for the syntheses of both 3-O-sialyl-or 3-O-sulfo-Le x and Le* type structures (Jain et al., 1996) Further details of the synthesis of compounds 44, 46, 47, and 50 will be published elsewhere (unpublished observations). Compounds 48 and 49 were synthesized as described elsewhere Vig et al., 1995) . The structure and purity of each compound was confirmed by TLC, NMR, and FAB mass spectroscopy. As seen in Figures 1-3 , many of these compounds are based upon previously known natural structures (2,4,5,46,49; see Table I ), but are synthesized with various modifications at the reducing termini. Others are structures that have not been shown in nature, but do carry features that are typical of mucin-type O-linked Scheme 3 chains (Capon et al, 1992; Mawhinney et al., 1992; Strous and Dekker, 1992; Lo-Guidice et al, 1994) , for example, the Core 2 structure found in oligosaccharides 35, 37, 40, 42, 50. In addition, several of these compounds (35, 37, 40, 42, 48 , and 50) contain modifications suggested as important for selectin recognition, such as the sulfate groups and al-3(4)fucosyl residues. Figure 4 , increasing chloride concentrations (at pH 7.45 and 4°C) had a substantial inhibitory effect upon the binding of all three selectins to SLe*. These results indicate that selectin-ligand binding likely involves ionic interactions. This fits well with the fact that the C-type lectin binding pockets of the selectins are rich in lysine residues (Erbe et al., 1992 (Erbe et al., , 1993 Hollenbaugh et al., 1993; Graves et al., 1994) , while the natural ligands are often polyanionic. It is notable that under the conditions typically used in previous studies (e.g., 150 mM NaCl in addition to the standard components of the buffer), selectin binding to immobilized SLe x would be decreased by almost 50%. As NaCl concentration is further increased, the effect is more substantial (Figure 4) , for example, 100 mM NaCl above physiological buffer conditions almost completely abolishes binding. Thus, many experimental conditions previously used may not have not been optimal for studying E-, L-, and P-selectin binding to such immobilized ligands. Furthermore, variations in pH from 7.1-7.7 also affected selectin-ligand interaction, with maximal binding seen at pH 7.1 and 75% of this value obtained at pH = 7.7 (data not shown). Based on these studies, we lowered the NaCl concentration in our ELJSA buffer to 125 mM, used 2 mM each of CaCl 2 and MgCl 2 (close to their physiological range in plasma), and kept the buffer concentration at 20 mM HEPES (pH adjusted to normal plasma value pH of 7.45). The effects of temperature was next studied under these optimized conditions (total anion concentration = 153 mM). Increasing temperatures gave some decrease in binding, with binding at 37°C being 45-50% of that at 4°C (data not shown). However, increasing temperatures also markedly increased the nonspecific (EDTA insensitive) background level of binding. Thus, we chose to carry out further studies at 4°C, using the "physiological" buffer and pH conditions listed above.
Synthesis of oligosaccharides as potential inhibitors of the selectins
General features of the inhibitory properties of the synthetic oligosaccharides
The panel of synthetic oligosaccharides were analyzed for their potential selectin inhibitory properties. A few of these have been previously studied, for example, compounds 2-5, and are included for comparison. As summarized in Table I (see also examples of the data in Figures 5-6) various combinations of a2-3-linked sialic acid residues, sulfate esters and al-3(4)fucosylation seem to contribute to binding. In general, sulfate esters at the 6-position seemed to improve binding when they were in the internal position but not at the terminal position (compare compounds 44 and 46 vs 45 and 48 in Table I ). In contrast, and as indicated from prior work (Yuen et al., 1994) , sulfate esters at the 3 position of terminal galactose residues increased binding efficiency (see compounds 3 and 5 in Table  I ). However, compound 50, which contains two sulfate esters linked via the 6-position, demonstrates poor inhibitory properties, indicating that the positions of the sulfate groups are important for selectin recognition and that sulfate multivalency alone does not necessarily improve selectin binding. As also shown in Table I , some S'sulfo-Le^'-based compounds are able to inhibit the binding of all three selectins to SLe*.
Similar inhibitory results obtained with immobilized SLe 1 or 3'sulfo-Le x as targets
The binding of the recombinant E-, P-, and L-selectin to immobilized SLe* and P-or L-selectin to 3'sulfo-Le* requires calcium, indicating that in each case, the calcium-dependent C-type lectin domain is involved. Prior reports have raised the possibility that the selectins may have partially or completely NeuAca2-3(SE-6)GalB 1 -3GlcNAcB 1 -OMe independent binding sites for sialic acids and sulfate esters (Hollenbaugh etal., 1993; Chou, 1995) . However, as shown in Table I , the relative inhibitory properties of the various oligosaccharides for each selectin did not seem to be markedly different when comparing results between the two different immobilized target structures. One interpretation of these data is that the binding sites for the sialylated and the sulfated oligosaccharides are very close, or identical. This does not preclude possible additional sulfate dependent interactions that are calcium-independent.
Potential importance of oligosaccharide branching in enhancing recognition by P-or L-selectin
At first glance, it appears that no other structural pattern predicts the best inhibitory properties of the compounds studied. However, as shown in Figure 6 , two branched, fucosylated structures 40 and 42 with sulfated galactose residues had some of the best inhibitory effects against P-and L-selectin, despite not carrying sialic acid residues (see Table I for IC 50 values of each). These two molecules are in fact similar to some 80 100 120 140 160 180 200 220 mM NaCI Fig. 4 . Effects of ionic strength on the binding of recombinant soluble selectins to immobilized SLe*. An ELJSA assay was used to study the effects of ionic strength on the binding of recombinant soluble selectins to immobilized SLex. NaCI was added in 10 mM increments to a standard ELISA buffer and the binding of the three selectins to immobilized SLe* was studied as described under Materials and methods. Data was applied to the formula: ([(average of duplicates) -(average of negative controls)]/ [(average of highest Abs492 duplicates) -(average of negative controls)]) x 100, where the highest Abs492 values contained 100 mM NaCI, and negative controls were assayed in the presence of 5 mM EDTA. The graph is one example of three separate experiments. Similar results were also obtained for P-and L-selectin binding to 3'sulfo-Le* (data not shown).
branched O-GalNAc-linked oligosaccharides that can be found on sulfated mucins, including GlyCAM-1 (Hemmerich et al., 1995) . Indeed, a comparison of the results obtained with compounds 40 and 42, versus 35 and 37 shows the importance of the Gaipi-4 residue on the GlcNAcf$l-6 branched arm in enhancing the inhibitory effects towards P-and L-selectin (see Table I ). In this regard, it is interesting that recent studies from others have suggested that branched O-linked chains containing the same Gaipi-3(GlcNAc31-6)GalNAc-O-Ser/Thr Core 2 sequence may have a role in enhancing binding to L-and P-selectin (Maaheimo et al., 1995; Li et ai, 1996) .
The major capping group of GlyCAM-1 is neither a superior nor a selective ligandfor L-selectin
While natural ligands demonstrate binding affinities for the selectins in the nanomolar range, many common sialylated fucosylated oligosaccharides show ICso values in the micromolar to millimolar range (Varki, 1994) . This genera] observation is confirmed and extended in this study for a wide range of compounds. One possible explanation for this is that the natural ligands bear unique oligosaccharide structures, for ex- Table I. ample, the natural L-selectin ligand GlyCAM-1 has the unusual oligosaccharide 6'-sulfo-SLe", in which a O-sulfate ester is attached to the 6-position of the galactose residue in SLe* (Hemmerich and Rosen, 1994; Hemmerich et al., 1994 Hemmerich et al., , 1995 . These studies concluded by predicting that this "major capping group" might be a much better ligand for L-selectin, thus explaining the high affinity binding of the parent glycoprotein. Although the enzymatic pathway for the synthesis of this structure has not yet been clearly elucidated, one of us has succeeded in its complete chemical synthesis . We therefore studied the inhibitory properties of this compound Inhibitor Concentration (uM) Fig. 6 . Comparison of the inhibitory properties of some branched sulfated, fucosylated oligosaccharides. The oligosaccharides were tested for their inhibitory properties in ELISA assays of all three selectin chimeras binding to immobilized Sle", and the data analyzed and presented as described in the Figure 5 caption. The averaged IC X values for each oligosaccharide are presented in Table I .
(49) towards the binding of recombinant E-, P-, and Lselectin to immobilized SLe* and P-or L-selectin to 3'sulfo-Le\ As shown in Figure 5 , this compound gave an IC^ value for L-selectin of -250 JJLM, and also inhibits P-selectin. However, unlike nonsulfated SLe*. it does not inhibit E-selectin, indicating that the sulfate group can impart some "negative" specificity among the selectins. In this regard, the sialyl-Le"-based isomer of this compound (48) was not as effective an inhibitor.
The major capping group of GlyCAM-1 not a superior inhibitor of L-selectin binding to GlyCAM-1 itself
The lack of superiority of 6'-sulfo-SLe* as an L-selectin inhibitor could also be explained by the fact that the target structures in the ELISA assay were polyacrylamide-based SLe*, and 3'-sulfo-SLe\ rather than the native ligands. We therefore studied the inhibitory properties of this compound against the direct binding of L-selectin to the natural glycoconjugate ligand GlyCAM-1 (see Materials and methods for details of this assay). The ICJQ for this interaction was 560 fiM (mean of two determinations, see example in Figure 7 ), somewhat worse than that with the artificial ligands used for the earlier ELISA assays. Furthermore, the inhibitory property of SLe* against this interaction was similar to that of the major capping group (ICJO = 590 ^.M, mean of four determinations, see example in Figure 7 ), again somewhat worse than against the artificial ligands (compare Figures 5 and 7) . Interestingly, the rest of the
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Inhibitor Concentration (mM) Fig. 7 . Inhibitory properties of the major capping group of GlyCAM-1 and other oligosaccharides against native GlyCAM-1 binding to L-selectin. GlyCAM-1 was partially purified from mouse serum by L-selectin affinity chromatography and captured by polyclonal anti-GlyCAM-1 antibodies coated on the wells of microtiter plates as described under Materials and methods. The oligosaccharides in serial dilution were mixed with the LS-Rg -secondary antibody complex prior to addition to the wells. Table I were tested, and the examples shown are: 2, SLe 1 ; 4, Sle*; 49, GlyCAM-1 major capping group; 40 and 42, branched oligosaccharides; 5, 3'HSO 3 Le" (see Table I for structural details).
Selectln-oligosaccharide interactions
oligosaccharides (including sialyl-Le x ) that had showed moderate inhibitory properties towards L-selectdn interactions with immobilized sialyl Le x /3'-sulfo-Le x (see Table I ) failed to show such properties against the binding with native Gly-CAM-1 (all IC^ values greater than 2 mM, data not shown). This assay should be more physiologically relevant in identifying inhibitors of natural L-selectin interactions. Thus, the discrepancies with the results of conventional ELJSA assays utilizing artificial ligands raise caution about the use of the latter in screening therapeutic compounds.
Regardless, it appears that the major capping by itself is insufficient to explain the high affinity interaction of L-selectin with GlyCAM-1. Eventually, it will be important to study the inhibitory properties of a completely sialylated and sulfated branched compound such as the one previously reported by others (Lo-Guidice et al., 1994) and recently described by Hemmerich and Rosen on GlyCAM-1 (Crommie and :
Fucal,, Siaa2-3Gaip 1 -4<SE-6)GlcNAcP 1 g Siaa2-3Gaip 1 -3GalN Aca 1 -OMe or a similar compound incorporating a SE-3Galf31-3GalNAcod-OMe sequence. The complete large scale synthesis of such compounds is a challenging task that we are currently pursuing.
Superior properties of sialyl-Le" in inhibiting all three selectins A surprising finding arising from all of the above data is that none of the compounds tested (including sialyl-Le Table I ). In general, sialyl-Le x with the type 2 backbone Gaipi-4GlcNAc has been the motif most associated with natural selectin ligands (Tamatani et al., 1995) , while the type 1 backbone of sialyl-Le a (Gaipi-3GlcNAc) is mainly associated with epithelial surfaces. For this reason, and because it is easier to synthesize, sialyl-Le x has received more attention than sialyl-Le". However, sialyl-Le a was noted early on to be recognized by the selectins (Berg et al, 1991) , and in at least one instance (cardiac allograft rejection in the rat), there is evidence that it is synthesized in a relevant cell type (endothelium) (Turunen et al., 1995) . It should also be noted that sialyl-Le* is found in the mucins of malignant epithelia such as colon carcinomas (Mannori et al., 1995) that would become exposed to selectins during tumor invasion.
Implications of these studies for the nature of high affinity recognition of natural ligands by the selectins
There is little doubt that highly multivalent displays of structures such as sialyl-Le x on either protein (Welply et al., 1994) or oligosaccharide (Turunen et al., 1995) backbones can generate avid binding to multivalently presented selectins. However, this does not seem to explain the high-affinity interactions of monovalent selectins with their natural ligands. Scudder and colleagues (Scudder et al., 1994) recently synthesized a structural isomer of the major capping group of GlyCAM-1 (6-sulfo-SLe x , in which a O-sulfate ester is attached to the 6-position of the GlcNAc residue in SLe x ), and showed an ICô f only 0.8 mM for the interaction of L-selectdn with lymph node derived peripheral addressins (representing a fourfold improvement over SLe x in inhibiting the same interaction). However, they raised the possibility that the high affinity interactions might require the sulfate to be at the 6-position of the galactose residue as in the native ligand GlyCAM-1. The present results appear to negate that possibility. Likewise, synthetic variations of some of the branched O-linked structures expected to be found on GlyCAM-1 did not reveal an oligosaccharide with clearly superior binding. In keeping with this, we have recently found that while subsets of sialylated sulfated mucins of diverse origins can bind to L-selectin, O-linked chains released from these mucins do not contain a highaffinity subset of chains (Crottet et al., 1996) . These studies, together the data reported here, suggest that rare structural variants of the common sialylated fucosylated oligosaccharides may not explain the high-affinity recognition of natural selectin ligands. Of course, we were not able to synthesize every possible sialylated, sulfated fucosylated structure that might be found among the O-linked chains of selectin ligands. Thus, as discussed earlier, it is possible that some complex form of branched Core 2 containing oligosaccharide might impart improved binding. Furthermore, some other unknown mechanism might operate in vivo to improve the binding affinity of any of these types of oligosaccharides.
Another possibility is the combination of a basic oligosaccharide sequence and an adjacent peptide, acting either by presenting a composite recognition site, or by forcing a monovalent oligosaccharide into an unusual conformation favored for recognition. Although the persistence of high affinity recognition following extensive denaturation or proteolytic digestion (Imai et al., 1992; Lasky et al., 1992; Moore et al, 1992; Norgard et al, 1993b; Norgard-Sumnicht et al., 1993) seems to be against this, recent studies suggest that tyrosine sulfate residues adjacent to sialylated oligosaccharides may create such a composite binding site for P-selectin on the natural ligand PSGL-1 (Pouyani and Seed, 1995; Sako et al, 1995; Wilkins et al., 1995) . A more complex variation involves recognition of a "clustered saccharide patch" (Norgard et al, 1993b) created by a polypeptide carrying multiple oligosaccharides. In this scenario, oligosaccharides packed closely together, such as in mucins, and having limited mobility could present a discontiguous saccharide epitope generated by multiple oligosaccharides. It is important to note that in all these instances, high affinity recognition would be lost if the arrangement is disrupted, and the individual sugar chains may not have detectable affinity for the selectin. This might explain why most reported high affinity selectin ligands are heavily glycosylated macromolecules, and the finding that free oligosaccharides released from such ligands do not bind with recognizable affinity to the same selectin (Imai et al, 1992; Norgard-Sumnicht et al., 1993; Crottet et al., 1996) . Such recognition is distinct from the improved binding of certain other lectins interacting with multiantennary N-linked oligosaccharides (Rice et al, 1990 (Rice et al, , 1991 , or with glycopeptides carrying widely spaced O-linked oligosaccharides (Lee, 1992) . This type of enhancement results from correct spacing of terminal sugar residues, each of which are still recognized as distinct components of individual chains by separate lectin domains of multidomain and/or clustered lectins.
It should also be pointed out that E-selectin may be a partial exception to these considerations. Recent studies have shown that a tetrantennary N-linked oligosaccharide with a sialylated polyfucosylated polylactosamine borne on the al-3Man linked arm of the sugar chain can bind with high affinity to immobilized E-selectin (Patel et al., 1994) . Interestingly, related structures can also be found on "myeloglycan," a family of sialylated polyfucosylated polylactosamine glycolipids from neutrophils (Stroud et al., 1995 (Stroud et al., , 1996 . Another complexity for consideration is the finding that P-and L-selectin can bind selectively and strongly to some heparin/heparan sulfate chains, despite being a very different class of glycoconjugates that do not carry sialic acids and fucose (Skinner et al., 1989; Nelson et al., 1993a; Norgard-Sumnicht et al., 1993) . Indeed, small heparin-derived oligosaccharides are capable of competing with L-and P-selectin binding to sLe x (Nelson et al., 1993a) , suggesting that the two classes of molecules (sialylated, fucosylated oligosaccharides and heparin oligosaccharides) might compete for the same binding site. One possible explanation is that these sulfated, uronic acid-rich polysaccharides are capable of mimicking the anionic surface of the recognition site for selectins that is created on the surface of certain mucin-type molecules. This is supported by our recent findings that only subsets of heparins and mucins are selectively recognized by L-selectin, and that oligonucleotides of defined structure can mimic these high-affinity ligands for Lselectin (O'Connell et al., 1996) . Further work is obviously needed to elucidate the nature of the natural high-affinity ligands for the selectins. Meanwhile, the systematic comparisons of the three selectins presented here indicate that the explanation for high affinity may not lie solely in the superior binding properties of unusual sulfated oligosaccharide structures. Rather, the branching, arrangement, and/or clustering of relatively common acidic oligosaccharides many produce unique binding motifs, with or without a direct contribution from the polypeptide carrier. This fits with recent studies showing that a sulfated tyrosine containing peptide can also be selectively recognized by P-selectin in the context of a sialylated, fucosylated oligosaccharide (Pouyani and Seed, 1995; Sako et al., 1995; Wilkins et al., 1995; Li et al., 1996) .
Implications of these studies for the therapeutic blockade of the selectins
While sialyl-Le x shows differential reactivity among the selectins (being a much poorer inhibitor of L-and P-selectin than of E-selectin), the present study shows that sialyl-Le" uniformly inhibits all three selectins with IC^ values in the low micromolar range. Sialyl-Le x in large quantities appears to be effective in various animal models of selectin-mediated pathologies (Albelda et al., 1994; Bevilacqua et al., 1994; Lefer et al., 1994) , and is currently in clinical trials for certain reperfusion states in humans. Based on the present work, it appears that strong consideration should be given to using sialyl-Le a in a similar fashion. On the other hand, despite the large amount of effort reported here in synthesizing many related sialylated, fucosylated and/or sulfated oligosaccharides, none so far have emerged as clearly superior inhibitors. Further efforts to synthesize more complete branched sialylated sulfated O-linked chains are worthwhile, since they may prove to be more potent. However, parallel efforts should be directed towards generating artificial inhibitors of the selectins, such as those based on peptides (Martens et al., 1995) , oligonucleotides (O'Connell et al., 1996) , and unrelated organic compounds from pharmacore searching (Narasinga Rao et al., 1994) . Of course, if the structural basis for high-affinity recognition of the natural selectin ligands could be elucidated with precision, this could lead to a more rational drug design of synthetic inhibitors.
Materials and methods
General methods for oligosaccharide synthesis
Optical rotations were measured at ~25°C with a Perkin-Elmer 241 Polarimeter. TLC was conducted on glass plates precoated wim a 0.25 mm layer of silica gel 60F-254 (Analtech GHLF uniplates). The compounds were located by exposure to UV light and (or) by spraying with 5% H 2 SO 4 in EtOH and charring on a hot plate. The silica gel used for column chromatography was Baker Analyzed (60-200 mesh). NMR spectra were recorded at ~25°C; 'Hspectra with a Varian EM-390 at 90 MHz and with a Brukcr AM-400 at 400 MHz and ' 3 C-spectra with a Bruker AM-400 at 100.6 MHz. All chemical shifts were referenced to tetramcthylsilane. Solutions in organic solvents were generally dried with anhydrous sodium sulfate. Dichloromethane, N,Ndimethylformamide, and 1,2-dichloroethane were kept dried over 4 A molecular sieves. Elemental analyses were performed by Robertson Laboratory, Madison, NJ. All new compounds gave satisfactory elemental analysis.
Preparation and characterization of synthetic oligosaccharides
The compounds 48 and 49 (see Table I ) were synthesized as described elsewhere Vig et al., 1995) . The following describes the intermediates and methods of syntheses of most of the remaining compounds used in this study. Some details regarding compounds 43-47 and SO will be published elsewhere.
Synthesis of 2 Jl ,4-tn-O-aeeryl-6-O-pivaloyl-aJfi-D-galactopyranosyl bromide (8) and fluoride (9)
Treatment of 1,2,3,4-di-O-isopropylidene-a-D-galactopyranose (10 g; 38.5 mmol) with pivaloyl chloride (3.45 ml; 46.1 mmol) in pyridine (100 ml) at room temperature (RT) followed by the hydrolysis with 80% aqueous acetic acid provided the intermediate 6. Compound 7 (10.45 g; 24.2 mmol) was readily converted, in high yield, the bromide 8 by treatment with 31% hydrogen bromide in glacial acetic acid (50 ml) containing a little acetic anhydride (2.5 ml) in dichloromethane (100 ml); 
Synthesis of benzyl 0-(5-acctamido-3J-dideoxy-D-glycero-a-D-galacto-2-nonulopyranosylonic acid)-(2-*3)-0-($-D-galactopyranosyl)-(I-*4}-2-acetamido-2-dcoxy-fi-D-glucopyranoside (I)
Glycosylation of benzyl 2-deoxy-2-phthalimido-6-O-pivaloyl-f3-Dglucopyranoside (4.0 g; 8.3 mmol) with fluoride 9 (4.6 g; 11.6 mmol) under Mukaiyama's conditions [SnCl 2 (1.8 g; 9.94 mmol)-AgOTf (2.54 g; 9.94 mmol)] (Mukaiyama et al., 1981) in 5:1 (v/v) dichloromethane-toluene (120 ml) in the presence of 4 A molecular sieves (7 g) and purification over silica gel using hexane-EtoAc Glycosylation of 16A (0.22 g; 0.3 mmol) with the sialic acid donor L3(Marra and Sinay, 1989) (0.35 g; 0.6 mmol) under N-iodosuccinimide (0.26 g; 0.9 mmol) triflic acid in propionitrile (Veeneman et al. ,1990 ) (10 ml) at -45°C for 2 h and purification over silica gel utilized 25% acetone in chloroform as eluent gave 19 in 61% yield; [a] D -8°C (c 0.4, CHC1 3 ) ; 'H-NMR (CD 2 C1 2 ): 8 7. 74-7.73 (m, 4 H, arom.), 7.16-7.11 (m, 5 H, arom.) A solution of 19 (0.18 g; 0.15 mmol) in pyridine (10 ml) containing LJI (Nicolaou et al., 1992) (0.15 g; 1.1 mmol) was stirred at 120°C for 3 h. The solvent was removed under reduced pressure and passed through small silica gel column using 4:1 (v/v) chloroform-methanol as an eluent to provide the acid derivative which on treatment with 5:1 (v/v) methanol-hydrazine hydrate (60 ml) at 80°C for 7 h and followed by N-acetylation in 1:1 (v/v) MeOH-CH 2 C1 2 (30 ml) with excess acetic anhydride at 0°C for 1 h and de-Oacetylation with methanol-MeONa for 48 h provided 1 in 53% yield after purification over silica gel using 
Synthesis of methyl 0-(5-aceuwudo-3J)-diacoxy-D-glycero-a-D-galacto-2-nonulopyranosylomc acid)-(2-^>3
Glycosylation of 11 (4.9 g; 12.02 mmol) with 9 (6.5 g; 16.8 mmol) under condition similar to those described for the preparation of 16 gave pi ->4 linked disaccharide 18 after silica gel column chromatography ( Hz, H-l"), 4.81 (d, J = 7 Hz, H-l), 4.76 (d, J = 7 Hz, H-l'), 3.50 (s, OMe), 2.76 (dd, J = 4.6 Hz, H-3"e), 2.03 and 2.02 (each s, 2xNAc), 1.79 (t, J = 12.1 Hz, H-3"a), 1.16 (d, J = 6.6 Hz, H-6"); 13 C-NMR: 8 100.74 (C-l'), 100.65 (C-l), 98.67 (C-2"), 97.56 (C-l"), 74.67 (C-3'), 74.30 (C-3), 73.88 (C-4), 61.61 (C-9"), 60.44 (C-6'), 58.67 (C-6), 56.10 (OMe), 54.59 (C-2), 50.70 (C-5"), 14.24 (C-6"); MS: m/z 833.3 [M-Na]".
Synthesis of methyl 0-(3-0-suIfo-fi-D-galactopyranosyl sodium salt)-(l-*4)-[a-L-fucopyranosyHl-*3)-0]-2-acetamido-2-deoxy-fi-Dglucopyranoside (3)
Regioselective sulfation of 21 (0.45 g; 0.5 mmol) with SO 3 -pyridine complex (0.48 g; 3 mmol) in pyridine (20 ml) at 5°C for 16 h and followed by the removal of protecting groups as described for the preparation of 2 from 22 gave title compound 3 in 37% yield after silica gel column chromatograpby (CHCl 3 - MeOH 
13 C-NMR: 8 100.72 (C-l'), 100.45 (C-l), 97.54 (C-l"), 79.20 (C-3'), 74.24 (C-3), 73.82 (CA), 60.31 (C-6'), 58.70 (C-6), 56.11 (OMe), 54.62 (C-2), 14.23 (C-6"); MS: m/z 622.3 [M-Na]".
Synthesis of O-{5-acetamido-3£-dideoxy-D-gtycero-cL-D-galacto-2-nonulopyranosylonic acid)-{2^t3yO-($-[>-galactopyranosyl)-{l-
Glycosylation of 12 (3.6 g; 8.8 mmol) with bromide 8 (5.3 g; 11.3 mmol) in the presence of Hg(CN>2 (2.8 g; 11.3 mmol) at 55° afforded compound 23 in 65% yield; [a] D -15° (c 0.8, CHC1 3 ; 'H-NMR (CD 2 C1 2 ): 8 7.33-7.27 (m, 5 H, arom.), 5.82 (d, J = 7.7 Hz, 1 H, NH), 5.37 (d, J = 3.1 Hz, 1 H, H-4'), 5.17 (dd, J = 8.0 Hz, 1 H, H-2'), 2.14, 2.05, 1.95, 1.94 (each s, 12 H, 3xOAc and NAc), 1.22, 1.17 (each s, 18 H, ixCMe,). Compound 23 (0.8 g; 1 mmol) on reaction with thiomethyl donor 14 (Sato et al., 1987; Jain and Marta, 1990) (1.15 g; 2.5 mmol) in 5:1 (v/v) dichloroethane-DMF (48 ml) in the presence of CuBr 2 (0.85 g; 3.5 mmol) and Bu 4 NBr (Sato et al., 1986) (1.12 g; 3.5 mmol) and 4 A molecular sieves (5 g) for 16 h afforded crude compound 24 which after de-O-acetylation with methanolic sodium metboxide gave compound 25 in 56% yield; 
0-{3-0-sulfo-$-D-galactopyranosyl sodium salt)-{I-*3)-[a-L-fucopyranosyl-(l-*4)-0]-2-acetamido-2-dcoxy-D-galacto-pyranose (5)
The procedure used for preparing known 5 (Lubineau et al., 1993) 
Synthesis of benzyl 0-(2,4fi-m-0-acetyl-3-0-chloroacetyl-^-Dgalactopyranosyl)-(l -^3)-2-acctamido-2-aeoxy-a-D-galactopyranoside (21)
Glycosylation of benzyl 2-acetamido-2-deoxy-4,6-0-methoxybenzylidene-ar>galactopyranoside (Piskorz et al., 1984) (3.2 g; 8.0 mmol) with 2,4,6-tri-Oacetyl-3-O-chloroacetyl-a-D-galactopyranosyl bromide (Jain and Matta, 1994) (5.5 g; 11.9 mmol) in the presence of Hg(CN) 2 (2.9 g; 11.9 mmol) at 55°C and followed by the removal of acetal ring with 60% aq. acetic arid at 70°C afforded 27 (2.7 g) in 50% yield; [a] D +88°C (c 1.0, CHC1 3 ); 'H-NMR (CDjClj): 8 7. 38-7.32 (m, 5 H, arom.), 5.55 (d, J = 9.9 Hz, 1 H, NH), 5.37 (d, J = 3.2 Hz, 1 H, H^'), 5.20 (dd, J = 7.9 Hz, 1 H, H-2'), 5.05 (dd, 1 H, H-2), 4.93 (d, J = 3.7 Hz, 1 H, H-l), 4.62 (d, J = 7.9 Hz, 1 H, H-l'), 3.98 (s, 2 H, COCH 2 C1), 2.14, 2.02, 2.01, 1.90 (each s, 12 H, 3xOAc and NAc). [0] [1] [2] 4, A similar glycosylation of methyl 2-acetamido-2-deoxy-4,6-0-methoxybenzylidene-a-D-galactopyranoside (1.4 g; 3.97 mmol) with bromide (2.8 g; 6.0 mmol) as described for the preparation of 27 afforded 28 (1. , 1 H,H^') , 5.19 (dd, J = 7.9 Hz, 1 H, 5.08 (dd, 1 H, 4.67 (d, 1 H, 4.65 (d, J = 7.9 Hz, 1 H, Glycosylation of methyl 2-acetamido-2-deoxy-4,6-O-metnoxybenzylidene-a-D-galactopyranoside (4.0 g; 11.3 mmol) with 2,3,4-tri-0-benzoyl-6-0-bromoacetyl-a-D-galactopyranosyl bromide (Kovac et al., 1985) (8-5 g; 12.5 mmol) under a similar reaction condition as described for the preparation of 27 gave compound 29 in 72% yield; [or] O-{23,4-tri-O-acetyl-a-L-fucopyranosyl)-(l->3)-4,6-di-0-acetyl-2-deoxy-2-phthalimido-l -thio-$-D-glucopyranoside (32) Methyl 4,6-O-benzyUdene-2-deoxy-2-phthalimido-P-D-glucopyranoside (3.0 g; 7.3 mmol) on reaction with methyl 2,3,4-tri-O-benzyl-l-thio-B-Lfucopyranoside (Sato et al., 1987; Jain and Matta, 1990 ) (4.2 g; 9.05 mmol) in 5:1 (v/v) dichloromethane-DMF in the presence of CuBr 2 (3.15 g; 13.5 mmol) and Bu 4 NBr (Sato et al., 1986) 
Synthesis of methyl
Synthesis ofphenyl
Synthesis of methyl
Glycosylation of 29 (1.0 g; 1.19 mmol) with donor 32 (1.04 g; 1.37 mmol) under N-iodosuccinimide (0.94 g; 42 mmol) triflic acid in CH 2 C1 2 (60 ml) for 1 h at -30°C and followed by the removal of bromoacetyl group with thiourea-2,6-lutidine afforded compound 34 (1. 
Benzyl 0-{a-L-fucopyranosyl)-{l -*3)-O-{2-acetamido-2-deoxy-$-[>-glucopyranosyl)-{l->6)-0-[3-0-sulfo-fi-D-galactopyranosyl-{l->3)-0]-2-acetamido-2-deoxy-a-D-galactopyranoside (37)
SelecUn-ollgosaecharide interactions
Materials for biological assays
Cell culture reagents were obtained from CORE Cell Culture Facility, San Diego, CA. Unless otherwise stated, most of the materials used were obtained from the Sigma Chemical Co. and were reagent grade or better. Other materials used are described in the text below.
Recombinam soluble selectins
The recombinant selectin receptor globulins (Rgs) used contain the extracellular domains of human selectins fused to the hinge and F c portion of human IgG. The L-selectin (LS-Rg) contains of the entire extracellular domain of a human L-selectin and human IgC^,. domain (Norgard et al., 1993a) ; the Eand P-selectin receptor globulin (ES-Rg and PS-Rg) contain the signal sequence, C-type lecrin domain, EGF domain, and six or two of the complement regulatory-like domains, respectively, attached to a human IgG,F c domain (Nelson et al., 1993b) . The E-and P-selectin chimeric proteins were constructed in pcDM8 vectors, and L-selectin in the vector pcDNAl. Each was stably expressed in 293 cells with G418 selection, and purified from the culture media using Protein A-Sepharose (PAS) as previously described (Nelson et al., 1993b) .
Enzyme-linked immunosorbent assays (ELJSA) for the lectin properties of the selectins
Inhibition assays. Sterile polystyrene 96 well ELISA plates (no. 25801, Coming, Coming, NY) were coated with 200 ng of polyacrylamide-SLe* or -HSO 3 Le* (no. 18205PA and no. 18605PA, respectively, Syntesome, Gesellschaft fur Medizinische Biochemie m.b.H., Munich, Germany) by overnight incubation at 4°C in 100 uJ of 50 mM sodium carbonate/bicarbonate buffer, pH 9.5. Plates were then blocked with 200 til per well of assay buffer 20 mM Hepes (no. 16926, U.S. Biochemical, Cleveland, OH), 125 mM NaCl, 2 mM CaClj, 2 mM MgCl 2 , 1% protease-free BSA (no. 82-045-1, Pentex, Miles, Inc., Kankakee, U.), pH 7.45 (osmolality 290 milliosmoles, determined with a Vapor Pressure Osmometer, model no. 55OOXR, Wescor Inc., Logan, UT) for a minimum of 2 h at 4°C. During the blocking step, the selectin chimeras were separately preincubated at 4°C with the secondary antibody, peroxidaseconjugated goat anti-human IgG (no. 109-035-098, Jackson Immunoresearch Laboratories, West Grove, PA) in assay buffeT for approximately 1 h. Final selectin-Rg concentration was 1 nM, and the optimal secondary antibody dilution was determined to be 1:1000 for the particular serum used. Potential inhibitors were serially diluted in assay buffer, at 2x the final required concentratiorL The selectin-Rg/secondary antibody stock was aliquoted into tubes containing an equivalent volume of inhibitor solution; buffer alone for the positive control, or buffer with 10 mM Na 2 EDTA, pH 7.5, for the negative control (final concentration 5 mM EDTA). These tubes were preincubated at 4°C for 30 min, and then added to ELJSA plates, in duplicates, at final well volume of 100 ul After 4 h of plate incubation at 4°C, plates were washed three times with 200 uJ per well of assay buffer at 4°C, followed by development with 150 u.1 per well of OPD solution at RT: 0.002 mg ophenylenediamine dihydrochloride (0PD)/ml in 50 mM sodium citrate, 50 mM disodium phosphate buffer, pH 5.2 containing 1 uJ/ml 30% H 2 O 2 . Using a timer, each well was sequentially quenched with 40 (il of 4 M H 2 SO 4 after a fixed time of peroxidase reaction. Softmax software and a microplate reader (Molecular Devices, Menlo Park, CA) determined and recorded absorbance at 492 nm. Prior to curve fitting, the data was changed into percentages for comparative purposes, using the formula: ([(average of duplicates) -(negative control)]/ [(positive control) -(negative control)]* 100) again with the Softmax software. For determination of IC X values, the data were iteratively fit (Nelson et al., 1993b) to a nonlinear least squares plot using SigmaPiot (Jandel Scientific, San RafaeL CA).
Effects of pH on selectin binding. Plates were prepared with immobilized polyacrylamide ligands and blocked as described above. Twelve tubes of assay buffer with increasing pH increments were prepared so that when added in an equivalent volume to the original assay buffer (pH 7.45) containing selectinantibody complexes, the final pH in the ELJSA plate wells ranged from 7.1 to 7.7. While carrying out the prebloclring in pH 7.45 assay buffer, Eppendorf tubes containing the final pH assay buffer and selectin chimera-secondary antibody were mixed and incubated for 30 min at 4°C, and then added to ELJSA plates, in duplicates, at final well volume of 100 u.1. After 4 h of 4°C incubation, plates were washed (each well with buffer of the appropriate pH) and developed as described above.
Effects of ionic strength on selectin binding. Plates were prepared with immobilized polyacrylamide ligands and blocked as described above. Twelve tubes of assay buffer 20 mM Hepes, 2 mM CaCl 2 ,2 mM MgCl 2 ,1% proteasefree BSA, pH 7.45, with increasing NaCl concentrations were prepared so that when added in an equivalent volume to assay buffer containing 100 mM NaCl (and 20 mM Hepes, 2 mM CaCl 2 , 2 mM MgCl 2> 1% protease-free BSA) and precomplexed selectin chimera-secondary antibody, the final NaCl concentration ranged from 100 mM NaCl to 210 mM, with increasing increments of 10 mM. Tubes containing the final mixtures were mixed and incubated for 30 min at 4°C, and then added to ELJSA plates, in duplicate, at final well volume of 100 |il. After 4 h of 4°C incubation, plates were washed three times with 200 uJ/well of assay buffer containing the NaCl concentrations corresponding to that originally present in each well. Binding was detected by developing with OPD solution as described above.
Effects of temperature on selectin binding. Plates were prepared with immobilized polyacrylamide ligands and blocked at 4°C as described above. During the last 30 min of blocking, plates were incubated at 4 C C at RT: 2O-22°C, or 37°C. In addition vials prepared as stated above with positive and negative controls (±5 mM EDTA) or serial dilutions of inhibitor (SLe\ compound 4). These were also preincubated in the appropriate temperature for 30 min. Contents of the tubes were aliquoted into ELJSA plate wells in 100 uJ volume and in duplicates. After 4 h incubation at 4°C, RT, or 37°C incubation, plates were washed with 200 u.l/well of assay buffer preincubated at the corresponding temperature. OPD development and following steps were done as described above.
Preparation of 35 S-labeled GlyCAM-1. The labeling and purification of secreted murine lymph node L-selectin ligands was carried out by a modification (Crottet et al., 1996) of previously reported methods (Imai et al., 1991; Lasky et al., 1992) . Briefly, lymph nodes slices were labeled with [ 33 S] Na^SO^ the supernatant was passed over wheat germ agglutinin Sepharose, and the material eluted with 0.2 M GIcNAc was subjected to affinity chromatography on LS-Rg-PAS. Bound ligands (primarily 33 S-labeled GlyCAM-1) were eluted with 2 mM EDTA Isolation of L-selectin ligands from mouse serum. It is known that Gly-CAM-1 is secreted by lymph node HEV into the mouse bloodstream (Hoke et al., 1995) . Soluble L-selectin ligands, including GlyCAM-1, were isolated from sterile mouse serum Rogers, AR) . Serum (5 ml, trace hemolyzed), was spiked with -3000 c.p.m. of "S-labeled GlyCAM-1 (see protocol above) and loaded directly onto an 0.6 mg/ml LSRg-PAS column (equilibrated in 20 mM Hepes, 125 mM NaCl, 2 mM CaCl 2 , 2 mM MgCl 2 , pH 7.45), followed by washing with the same buffer. Specifically bound material was eluted with 2 mM EDTA, 20 mM Hepes, 125 mM NaCl, pH 7.45, and was followed by counting 10% of each fraction collected. Complete binding of the radioactivity ensured that the column was not overloaded, and complete recovery ensured that elution was complete. This process was repeated six times (30 ml total of mouse serum ran over the LS-Rg-PAS column). The fractions containing the majority of tbe EDTA-eluted material were pooled and used for inhibition assays described below. As expected, this material included GlyCAM-1 (detected by dot blotting using anli-GlyCAM-1 antibody, data not shown).
Assay for L-selectin binding to GlyCAM-1. The following steps were performed at 4°C unless otherwise stated. ELJSA plate (Coming, no. 25801, Coming, NY) wells were coated with 0.6 u.g of rabbit monospecific polyclonal anti-GlyCAM-1 antibody (a kind gift from Susan Watson, Genentech) in 100 MJ of 50 mM Na 2 CO3/NaHCO 3 buffer, pH 9.5 per well at 22°C for 1-1.5 h. The wells were then blocked with 200 uJ per well of ELISA assay buffeT containing BSA (see above) for 2 h. Mouse serum L-selectin ligands (see above for isolation) were added (0.6 u.g per 100 u.1 of ELJSA assay buffer per well), incubated overnight to allow specific capture of GlyCAM-1, and wells washed once with 200 uJ per well of ELISA assay buffer. The addition of serially diluted oligosaccharide inhibitors mixed with the LS-Rg-secondary antibody complexes to wells was done exactly as described for the ELJSA inhibition assays above. Loss of binding in the absence of added mouse serum ligands, or in the presence of 5 mM EDTA, confirmed the specificity of binding. Binding was read, data was converted to percentages and IC^j values were generated by fitting data to a nonlinear least-squares curve, exactly as described above for the ELJSA inhibition assays.
